Two Sigma Securities’s Terns Pharmaceuticals TERN Stock Holding History

Two Sigma Securities’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,908	Closed	-$628K	–	2353
2026 Q1	$628K	Buy	+11,908	New	+$489K	0.07%	385

Other funds holding TERN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Two Sigma Securities's TERN Position: Q2 2026 in Review

Two Sigma Securities sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 11,908 shares — an estimated $628K sold.

Two Sigma Securities first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $628K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Two Sigma Securities reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 11,908 Terns Pharmaceuticals shares in Q2 2026, an estimated $628K.
Two Sigma Securities first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Two Sigma Securities's Terns Pharmaceuticals position peaked at $628K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.